An approach to the design of a particulate system for oral protein delivery.ii. preparation and stability study of rhGH-loaded microspheres in simulated gastrointestinal fluids

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 183-192

  Nafissi Varcheh, Nastaran ^a   Aboofazeli, Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biodegradable polymer; Microencapsulation; Microparticle; Oral protein delivery

Indexed keywords

HUMAN GROWTH HORMONE; MICROSPHERE; RESOMER; RG 207; RG 505; RG 756; UNCLASSIFIED DRUG; ZINC;

AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; GASTROINTESTINAL TRACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; MICROENCAPSULATION; NANOFABRICATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN STABILITY;

EID: 79959431760     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Giteau A, Venier-Julienne MC, Marchal S, Courthaudon JL, Sergent M, Montero-Menei C, Verdier JM and Jean-Pierre Benoit JP. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur. J. Pharm. Biopharm. (2008) 70: 127-136.
2. Ghassemi AH, van Steenbergen MJ, Talsma H, van Nostrum CF, Jiskoot W, Crommelin DJA and Hennink WE. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J. Control Rel. (2009) 138: 57-63.
3. Sinko PJ, Succi G and Lee YH. Non-invasive peptide and protein delivery. In: Swarbrick J and Boylan JC. (eds.) Encyclopedia of Pharmaceutical Technology. Marcel Dekker, Basel (2002) 1883-1900.
4. Mustata G and Dinh SM. Approaches to oral drug delivery for challenging molecules. Crit. Rev. Therap. Drug Carr. Sys. (2006) 23: 111-135.
5. Allemann E, Leroux J and Gurny R. Polymeric nano-and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug. Del. Rev. (1998) 34: 171-189.
6. Andrianov AK and Payne LG. Polymeric carriers for oral uptake of microparticulates. Adv. Drug Del. Rev. (1999) 34: 155-170.
7. Singh M, Shirley B, Bajwa K, Samara E, Hora M and O'Hagan D. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. J. Control Rel. (2001) 70: 21-28.
8. Berkland Q Kim KK and Packl DW. PLG microsphere size controls drug release rate through several competing factors. Pharm. Res. (2003) 20: 1055-1062.
9. Sinha VR and Trehan A. Biodegradable microspheres for protein delivery. J. Control Rel. (2003) 90: 261-280.
10. Aubert-Pouessel A, Venier-Julienne MC, Clavreul A, Sergent M, Dollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P and Benoit JP. In-vitro study of GDNF release from biodegradable PLGA microspheres. J. Control Rel. (2004) 95: 463-475.
11. Duvvuri S, Janoria KG and Mitra AK. Development of a novel formulation containing poly (D,L-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. J. Control Rel. (2005) 108: 282-293.
12. Fu X, Ping Q and Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in-vitro of huperzine A-PLGA microspheres. J. Microencapsul. (2005) 22: 705-714.
13. Bao W, Zhou J, Luo J and Wu D. PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. J. Microencapsul. (2006) 23: 471-479.
14. Danoria KG and Mitra AK. Effect of lactide/glycolide ratio on the in-vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Int. J. Pharm. (2007) 338: 133-141.
15. Kim HK, Chung HJ and Park TG. Biodegradable polymeric microspheres with open/closed pores for sustained release of human growth hormone. J. Control Rel. (2006) 112: 167-174.
16. Takada S, Yamagata Y, Misaki M, Taira K and Kurokawa T. Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique. J. Control Rel. (2003) 88: 229-242.
17. Nafissi-Varcheh N, Erfan M and Aboofazeli R. An approach to the design of a particulate system for oral protein delivery. I. In-vitro stability of various poly (a-hydroxy acids)-microspheres in simulated gastrointestinal. J. Microencapsul. (2008) 25: 584-592.
18. Gietz U, Arvinte T, Haner M, Aebi U and Merkle HP. Formulation of sustained release aqueous Zn-hirudin suspensions. Eur. J. Pharm. Sci. (2000) 11: 33-41.
19. Nafissi-Varcheh N, Luginbuehl V, Aboofazeli R and Merkle HP. Preparing poly (lactic-co-glycolic acid) (PLGA) microspheres containing lysozyme-zinc precipitate using a modified double emulsion method. Iranian J. Pharm. Res. (2011) 10: 203-210.
20. Nafissi-Varcheh N, Shafaati A, Zarghi A and Aboofazeli R. Development of a reversed-phase HPLC method for stability study of somatropin. Iranian J. Pharm. Res. (2005) 3: 209-213.
21. Desai MP, Labhasetwar V, Walter E, Levy RJ and Amidon GL. The mechanism of uptake biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. (1997) 14: 1568-1573.
22. Chen H and Langer R. Oral particulate delivery: Status and future trends. Adv. Drug Del. Rev. (1998) 34: 339-350.
23. Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX and Kissel T. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. (2000) 50: 147-160.
24. Delie F and Blanco-Prieto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules (2005) 10: 65-80.
25. Norris DA, Puri N and Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Del. Rev. (1998) 34: 135-154.
26. Carino GP, Jacob JS and Mathiowitz E. Nanosphere based oral insulin delivery. J. Control Rel. (2000) 65: 261-269.
27. Cleland JL, Johnson OL, Putney S and Jones AJS. Recombinant human growth hormone poly (lactic-co-glycolic acid) microsphere formulation development. Adv. Drug Del. Rev. (1997) 28: 71-84.
28. Yamagata Y, Misaki M, Kurokawa T, Taira K and Takada S. Preparation f a co-poly (dl-lactic/glycolic acid)- zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone. Int. J. Pharm. (2003) 251: 133-141.
29. Kim JK and Park TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol. Bioeng. (1999) 65: 659-667.
30. Wang W. Protein Aggregation and its inhibition in biopharmaceuticals. Int. J. Pharm. (2005) 289: 1-30.